Clinical Trials Logo
  1. Home
  2. Benzodiazepine Dependence
  3. NCT02127411

Effectiveness of Mindfulness Based Relapse Prevention for Chronic Users of Benzodiazepines — MBRP  

Benzodiazepine Dependence Clinical Trial

Official title:
Adaptation and Evaluation of the Mindfulness-Based Relapse Prevention Program for Cessation and/or Reduction of Benzodiazepine Chronic Use to Induce Sleep Among Women

Clinical Trial Summary

Benzodiazepines (BZD) are the most prescribed psychiatric drugs in Brazil, especially for women. Although it is recommended that the use of BZD is not greater than four weeks, there are many cases of prolonged use due to the lack of treatment options for dealing with complaints of insomnia. Given this, the aim of this project is to evaluate the program Mindfulness-Based Relapse Prevention (MBRP) for adult women with chronic use of benzodiazepine (BZD) to induce sleep. Specifically aims to evaluate if the MBRP program, can reduce the pattern of use and level of dependence of chronic users of BZD under gradual reduction (tapering) or cessation of the use of BZD. This study will be conducted at the Drug Dependency Unit (UDED) of the Department of Psychobiology of Federal University of São Paulo. The study will count with two groups: intervention group (IG) and control group (CG) (that will stay in the waitlist until the eighth month . The sample will comprise 100 women with chronic use of BZD as hypnotics, 50 will be randomized in the IG condition and 50 in the CG condition. Changes will be evaluated on several variables such as cessation and dependence of BZD, quality of life, sleep, anxiety, depression and sexual satisfaction before and after the intervention in both groups. The data will be submitted to descriptive and inferential bivariate and multivariate statistic analyzes. It is hoped that this study create subsidies for the development of complementary interventions for the management of withdrawal symptoms in chronic users of BZD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02127411
Study type Interventional
Source Federal University of São Paulo
Contact
Status Completed
Phase N/A
Start date October 2013
Completion date December 2016
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT04533230 - Prevention of Benzodiazepine Misuse in Primary Care N/A
Terminated NCT03192514 - Electronic Deprescribing Tool for the Prevention of PIP N/A
Not yet recruiting NCT05765656 - Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly N/A
Not yet recruiting NCT05935553 - Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence Phase 2/Phase 3
Completed NCT03937180 - Blended Care for the Discontinuation of Benzodiazepine Use N/A
Active, not recruiting NCT04572750 - Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention N/A
Recruiting NCT02475538 - Electroacupuncture for Tapering Off Long-term Benzodiazepine Use N/A
Terminated NCT01893632 - Gabapentin Treatment of Benzodiazepine Dependence Phase 2
Completed NCT00420771 - Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients Phase 2
Recruiting NCT06250842 - Benzodiazepine Impact on Cognitive Function: fNIRs and PET/MRI Study
Completed NCT03971097 - The Effect of Self-Forgiveness on Self-Stigma in Addiction. N/A
Not yet recruiting NCT06359314 - Anxiety Lowering and Deprescribing Through Emotion Regulation N/A